GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

GENIL

TREGENL00024

Pharmaceuticals

Market Closed - Borsa Istanbul Other stock markets 16:09:49 15/05/2024 BST			5-day change	1st Jan Change
58.9 ^TRY	+5.37%		-0.67%	+25.64%

04-06	Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

RS Research announced that it has received TRY 12 million in funding from Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, One Life Ventures GmbH, and other investor

December 16, 2021

RS Research announced that it has received $12 million led by Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi on December 17, 2021. The transaction included participation from One Life Ventures GmbH and Eczacibasi Momentum.

Latest news about Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023	04-05	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2023	08/05/23	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi(IBSE:GENIL) added to FTSE All-World Index	20/03/23	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022	03/03/23	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022	03/03/23	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	06/11/22	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2022	10/05/22	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2021	04/03/22	CI
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi(IBSE:GENIL) added to S&P Global BMI Index	20/12/21	CI
RS Research announced that it has received TRY 12 million in funding from Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, One Life Ventures GmbH, and other investor	16/12/21	CI
Galventa announced that it has received €0.696 million in funding from Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi	03/10/21	CI
ARIAD Pharmaceuticals, Inc Announces Commercial Distribution Agreement with Gen Ilac for Iclusig(Ponatinib) in Turkey	06/05/15	CI

Chart Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Duration

Period

Chart Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

More charts

Company Profile

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is a Turkey-based company, which engages in manufacturing of pharmaceuticals and other health products. The Company operates in the fields of manufacturing all kinds of pharmaceuticals for human use and health products, trading, import and export. Gen Ilac manufactures products used in the treatment of rare diseases and disorders in neurology, endocrinology, nephrology, oncology, hematology and pediatric branches. The Company has approximately 500 employees working in its production facilities on a closed area of 15,000 square meters, established on an area of approximately 43,000 square meters in Ankara ASO 2nd and 3rd Organized Industrial Zone. Entity has 5 offices abroad: Germany, Russia, Kazakhstan, Uzbekistan and Azerbaijan.

Sector

Pharmaceuticals

Calendar

11/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI	+25.64%	520M
NOVO NORDISK A/S	+31.37%	588B
JOHNSON & JOHNSON	-3.14%	364B
MERCK & CO., INC.	+19.47%	326B
ABBVIE INC.	+5.18%	285B
ASTRAZENECA PLC	+14.83%	239B
NOVARTIS AG	+9.93%	210B
ROCHE HOLDING AG	-6.95%	200B
AMGEN INC.	+10.37%	167B
PFIZER, INC.	+0.48%	161B